Vendor, Boston, MA
Satio Inc.
UEI H8WFVFLRQYN3, CAGE 9DLB1
2 awards and -$536,094 obligated between March 7, 2024 and February 3, 2026, 50% under full and open competition, against 2.0 offers on average where reported.
Sells to
Awarding agencies by dollars.
| National Institutes of Health | $0 |
| Office of Assistant Secretary for Preparedness and Response | -$536,094 |
Industries
NAICS on the awards, by dollars.
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Full and Open Competition | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 2 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N91023C00059Definitive Contract, March 7, 2024, Full and Open Competition After Exclusion of Sources, 3 offers | NIH NCINational Institutes of Health | Development of Digital Satiorx, a Very Low Cost Remotely Controllable Disposable Microneedle Transdermal Drug Delivery Device Able to DeliveNAICS 541715, PSC AN13 | $0 |
| 75A50123C00043Definitive Contract, May 20, 2024, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Research and Development - Aoi #20 for the Development of a Low-Cost, Integrated, Lateral Flow Immunoassay and Blood Collection Diagnostic fNAICS 541714, PSC AN13 | -$536,094 |
- Places of performance
- Massachusetts
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 7 across 2 awards